Oligonucleotide Manufacturing at Scale: Why Integration, Automation, and System Design Matter
The commercial trajectory of oligonucleotide therapeutics is changing the manufacturing conversation. As more programs advance through clinical development and move toward commercialization, the central question is no longer whether oligonucleotides can be produced at scale. ... Continued
